Email this article 
INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER
- Authors: Alekseyev B.Y.1, Nyushko K.M.1
-
Affiliations:
- P.A. Herzen Moscow Oncological Research Institute
- Issue: Vol 5, No 4 (2009)
- Pages: 7-12
- Section: LECTURE
- Published: 30.12.2009
- URL: https://oncourology.abvpress.ru/oncur/article/view/282
- DOI: https://doi.org/10.17650/1726-9776-2009-5-4-7-12
- ID: 282
Cite item
Full Text
Abstract
Intermittent hormone therapy (IHT) is an effective and safe hormonal method in patients with prostate cancer (PC), which is as efficacious as continuous hormone therapy. IHT substantially improves quality of life at a therapy-free interval and reduces the cost of the performed therapy. IHT
About the authors
B. Ya. Alekseyev
P.A. Herzen Moscow Oncological Research Institute
Author for correspondence.
Email: byalekseev@mail.ru
Russian Federation
K. M. Nyushko
P.A. Herzen Moscow Oncological Research Institute
Email: byalekseev@mail.ru
Russian Federation
References
Supplementary files
